BLPH insider trading

Bellerophon Therapeutics, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades
207
Last 90 days
0
Buys / sells
32% / 5%
Market cap

BLPH insider activity at a glance

FilingIQ has scored 207 insider transactions for BLPH since Feb 12, 2015. The most recent filing in our index is dated Oct 13, 2023.

Across the full history, 67 open-market purchases and 11 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on BLPH insider trades is 53.1/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

Latest BLPH Form 4 filings

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Frequently asked

How many insider trades does FilingIQ track for BLPH?
FilingIQ tracks 207 Form 4 insider transactions for BLPH (Bellerophon Therapeutics, Inc.), covering filings from Feb 12, 2015 onwards. 0 of those were filed in the last 90 days.
Are BLPH insiders net buyers or net sellers?
Across the full Form 4 history for BLPH, 67 transactions (32%) were open-market purchases and 11 (5%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does BLPH insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

Methodology & sources

Every BLPH insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.